1,000 answered a patient survey of opioid maintenance treatment
Apr. 5, 2018 1:18 PM
SERAF and ProLAR have published the first scientific article that reports patient satisfaction and side effects of all three OMT medications, from a survey answered by more than 1,000 patients. ProLAR designed and implemented the survey, and SERAF helped analyze the data.
Half of substance users have recently been victims of crime
Nov. 16, 2017 1:18 PM
Victimization was associated with symptoms of poor mental health, more serious substance use and unstable housing.
Extended-release naltrexone as effective as buprenorphine-naloxone on retention in treatment and reducing use of heroin and other Illicit opioids in head-to-head comparison trial
Oct. 20, 2017 11:57 AM
In the 12-week, open-label, randomized-controlled study, 159 patients with opioid dependence were randomized to treatment with either extended-release naltrexone or buprenorphine-naloxone, following detoxification.